You are here

diabetes

Medtronic Is Sweet on EOFlow

Medical Devices and Diagnostics Industry

Thu, 05/25/23 - 12:46 pm

What you need to know about pharma, PBM execs testifying on insulin prices

Medical Marketing and Media

Wed, 05/10/23 - 11:15 pm

No Layoffs Here: Senseonics to Expand Sales Team

Medical Devices and Diagnostics Industry

Wed, 05/10/23 - 11:11 pm

continuous glucose monitoring

Medtronic diabetes warning letter lifted by FDA

Medtech Dive

Wed, 04/26/23 - 09:53 am

Medtronic wins FDA approval for long-delayed MiniMed 780G insulin pump

Medtech Dive

Tue, 04/25/23 - 11:38 am

See you later, Baqsimi: Lilly sells low blood sugar rescue treatment to Amphastar for $500M-plus

Fierce Pharma

Mon, 04/24/23 - 10:29 am

What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take

Fierce Pharma

Fri, 04/21/23 - 10:22 am

Novo’s latest deal targets cell therapy for diabetes, obesity

BioPharma Dive

Thu, 04/13/23 - 12:02 pm

Aspect Biosystems

Bernie Sanders weighs Senate hearing for largest insulin makers

Seeking Alpha

Thu, 04/13/23 - 11:53 am

Abbott’s CGM Readers Face Class I Recall Over Lithium-ion Battery Issues

Medical Devices and Diagnostics Industry

Tue, 04/11/23 - 07:12 pm

FreeStyle Libre

Abbott glucose monitor readers could catch fire, FDA warns in recall notice

Stat

Fri, 04/7/23 - 01:46 pm

product recalls

blood glucose monitoring

Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes

Xtalks

Fri, 04/7/23 - 01:43 pm

Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market

Motley Fool

Thu, 04/6/23 - 11:29 am

Diabesity drugs and their free ‘contract sales force’

Medical Marketing and Media

Tue, 04/4/23 - 10:12 am

Biomea goes for $125M offering after early diabetes data nearly doubled stock price

Endpoints

Wed, 03/29/23 - 10:05 am

clinical trials

Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality

Endpoints

Tue, 03/28/23 - 11:46 am

Vertex Pharmaceuticals

CRISPR Therapeutics

Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries

Fierce Pharma

Mon, 03/27/23 - 11:23 am

clinical trials

The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win

Investors Business Daily

Sun, 03/26/23 - 11:28 pm

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

CP Wire

Sun, 03/26/23 - 03:44 pm

PTC Therapeutics

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Sun, 03/26/23 - 03:36 pm

PTC Therapeutics

Pages